Lupin Gets US Regulator's Nod For Vasomotor Drug

New Delhi: Drug firm Lupin has received final approval from the US Food and Drug Administration (FDA) for its generic Amabelz tablets in the American market. The company has received "final approval for its Amabelz tablets (Estradiol and Norethindrone Acetate tablets USP, 0.5 mg / 0.1 mg and 1 mg / 0.5 mg)" from the US health regulator, it said in a filing to the BSE. The company's tablets are a generic version of Amneal Pharmaceut...